CRSP
Price
$40.72
Change
+$0.34 (+0.84%)
Updated
Dec 20 closing price
57 days until earnings call
KNSA
Price
$20.28
Change
-$0.31 (-1.51%)
Updated
Dec 23, 11:11 AM (EDT)
65 days until earnings call
Ad is loading...

CRSP vs KNSA

Header iconCRSP vs KNSA Comparison
Open Charts CRSP vs KNSABanner chart's image
CRISPR Therapeutics AG
Price$40.72
Change+$0.34 (+0.84%)
Volume$3.35M
CapitalizationN/A
Kiniksa Pharmaceuticals International
Price$20.28
Change-$0.31 (-1.51%)
Volume$400
CapitalizationN/A
CRSP vs KNSA Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. KNSA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and KNSA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (CRSP: $40.72 vs. KNSA: $20.59)
Brand notoriety: CRSP and KNSA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 188% vs. KNSA: 190%
Market capitalization -- CRSP: $3.48B vs. KNSA: $1.49B
CRSP [@Biotechnology] is valued at $3.48B. KNSA’s [@Biotechnology] market capitalization is $1.49B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileKNSA’s FA Score has 1 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • KNSA’s FA Score: 1 green, 4 red.
According to our system of comparison, KNSA is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while KNSA’s TA Score has 5 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • KNSA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KNSA is a better buy in the short-term than CRSP.

Price Growth

CRSP (@Biotechnology) experienced а -6.99% price change this week, while KNSA (@Biotechnology) price change was +1.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

KNSA is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.48B) has a higher market cap than KNSA($1.49B). KNSA YTD gains are higher at: 17.389 vs. CRSP (-34.952). KNSA has higher annual earnings (EBITDA): -24.4M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. KNSA (224M). KNSA has less debt than CRSP: KNSA (10.6M) vs CRSP (228M). KNSA has higher revenues than CRSP: KNSA (384M) vs CRSP (200M).
CRSPKNSACRSP / KNSA
Capitalization3.48B1.49B234%
EBITDA-313.08M-24.4M1,283%
Gain YTD-34.95217.389-201%
P/E RatioN/A164.54-
Revenue200M384M52%
Total Cash1.94B224M864%
Total Debt228M10.6M2,151%
FUNDAMENTALS RATINGS
CRSP vs KNSA: Fundamental Ratings
CRSP
KNSA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
94
Overvalued
PROFIT vs RISK RATING
1..100
10053
SMR RATING
1..100
9390
PRICE GROWTH RATING
1..100
8457
P/E GROWTH RATING
1..100
831
SEASONALITY SCORE
1..100
n/a5

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (62) in the Biotechnology industry is in the same range as KNSA (94) in the Pharmaceuticals Major industry. This means that CRSP’s stock grew similarly to KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (53) in the Pharmaceuticals Major industry is somewhat better than the same rating for CRSP (100) in the Biotechnology industry. This means that KNSA’s stock grew somewhat faster than CRSP’s over the last 12 months.

KNSA's SMR Rating (90) in the Pharmaceuticals Major industry is in the same range as CRSP (93) in the Biotechnology industry. This means that KNSA’s stock grew similarly to CRSP’s over the last 12 months.

KNSA's Price Growth Rating (57) in the Pharmaceuticals Major industry is in the same range as CRSP (84) in the Biotechnology industry. This means that KNSA’s stock grew similarly to CRSP’s over the last 12 months.

KNSA's P/E Growth Rating (1) in the Pharmaceuticals Major industry is significantly better than the same rating for CRSP (83) in the Biotechnology industry. This means that KNSA’s stock grew significantly faster than CRSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPKNSA
RSI
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
81%
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CVQZX8.580.11
+1.30%
Columbia Disciplined Value Inst
WPVLX32.570.37
+1.15%
Weitz Multi Cap Equity-Investor Cl
LVAMX12.030.11
+0.92%
LSV US Managed Volatility Investor
JGMIX24.700.16
+0.65%
Janus Henderson Triton S
FEBCX13.210.07
+0.53%
First Eagle Global Income Builder C

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+0.49%
NTLA - KNSA
41%
Loosely correlated
+0.83%
ABVC - KNSA
40%
Loosely correlated
+1.22%
FATE - KNSA
39%
Loosely correlated
+1.20%
CRSP - KNSA
36%
Loosely correlated
+0.83%
AMRN - KNSA
36%
Loosely correlated
-1.18%
More